These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 17934179
21. Prevalence of ADHD diagnosis and nonmedical prescription stimulant use in medical students. Tuttle JP, Scheurich NE, Ranseen J. Acad Psychiatry; 2010; 34(3):220-3. PubMed ID: 20431104 [Abstract] [Full Text] [Related]
22. Sleep characteristics of children and adolescents with attention deficit-hyperactivity disorder. Gruber R. Child Adolesc Psychiatr Clin N Am; 2009 Oct; 18(4):863-76. PubMed ID: 19836693 [Abstract] [Full Text] [Related]
23. Changes in use of psychostimulant medication for ADHD in South Australia (1990-2006). Prosser B, Reid R. Aust N Z J Psychiatry; 2009 Apr; 43(4):340-7. PubMed ID: 19296289 [Abstract] [Full Text] [Related]
24. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review. Findling RL. Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941 [Abstract] [Full Text] [Related]
25. Nonmedical use of prescription stimulants in the United States. Kroutil LA, Van Brunt DL, Herman-Stahl MA, Heller DC, Bray RM, Penne MA. Drug Alcohol Depend; 2006 Sep 15; 84(2):135-43. PubMed ID: 16480836 [Abstract] [Full Text] [Related]
26. A controlled study of autonomic nervous system function in adults with attention-deficit/hyperactivity disorder treated with stimulant medications: results of a pilot study. Schubiner H, Hassunizadeh B, Kaczynski R. J Atten Disord; 2006 Nov 15; 10(2):205-11. PubMed ID: 17085631 [Abstract] [Full Text] [Related]
27. Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design. Raman SR, Marshall SW, Haynes K, Gaynes BN, Naftel AJ, Stürmer T. Inj Prev; 2013 Jun 15; 19(3):164-70. PubMed ID: 23143347 [Abstract] [Full Text] [Related]
28. Stimulant medication use and response to growth hormone therapy: an NCGS database analysis. Frindik JP, Morales A, Fowlkes J, Kemp S, Thrailkill K, Lippe B, Dana K. Horm Res; 2009 Jun 15; 72(3):160-6. PubMed ID: 19729947 [Abstract] [Full Text] [Related]
29. Explaining racial and ethnic differences in children's use of stimulant medications. Hudson JL, Miller GE, Kirby JB. Med Care; 2007 Nov 15; 45(11):1068-75. PubMed ID: 18049347 [Abstract] [Full Text] [Related]
30. Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: results from a national sample. Waring ME, Lapane KL. Pediatrics; 2008 Jul 15; 122(1):e1-6. PubMed ID: 18595954 [Abstract] [Full Text] [Related]
31. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder. Upadhyaya HP. J Clin Psychiatry; 2007 Jul 15; 68 Suppl 11():23-30. PubMed ID: 18307378 [Abstract] [Full Text] [Related]
32. Do attention deficits influence IQ assessment in children and adolescents with ADHD? Jepsen JR, Fagerlund B, Mortensen EL. J Atten Disord; 2009 May 15; 12(6):551-62. PubMed ID: 18815437 [Abstract] [Full Text] [Related]
33. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample. Yang P, Hsu HY, Chiou SS, Chao MC. Aust N Z J Psychiatry; 2007 Dec 15; 41(12):998-1004. PubMed ID: 17999272 [Abstract] [Full Text] [Related]
34. Improving psychostimulant adherence in children with ADHD. Charach A, Gajaria A. Expert Rev Neurother; 2008 Oct 15; 8(10):1563-71. PubMed ID: 18928348 [Abstract] [Full Text] [Related]
35. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder. Kahbazi M, Ghoreishi A, Rahiminejad F, Mohammadi MR, Kamalipour A, Akhondzadeh S. Psychiatry Res; 2009 Aug 15; 168(3):234-7. PubMed ID: 19439364 [Abstract] [Full Text] [Related]
36. Growth and sexual maturation in children and adolescents with attention deficit hyperactivity disorder. Poulton A. Curr Opin Pediatr; 2006 Aug 15; 18(4):427-34. PubMed ID: 16914999 [Abstract] [Full Text] [Related]
37. Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects. Williams LM, Hermens DF, Palmer D, Kohn M, Clarke S, Keage H, Clark CR, Gordon E. Biol Psychiatry; 2008 May 15; 63(10):917-26. PubMed ID: 18272140 [Abstract] [Full Text] [Related]
38. Injury-proneness of youth with attention-deficit hyperactivity disorder: a national clinical data analysis in Taiwan. Tai YM, Gau SS, Gau CS. Res Dev Disabil; 2013 Mar 15; 34(3):1100-8. PubMed ID: 23340027 [Abstract] [Full Text] [Related]
39. Stimulants and sudden death: what is a physician to do? Wilens TE, Prince JB, Spencer TJ, Biederman J. Pediatrics; 2006 Sep 15; 118(3):1215-9. PubMed ID: 16951018 [Abstract] [Full Text] [Related]
40. Increased risk of injury in children with developmental disabilities. Lee LC, Harrington RA, Chang JJ, Connors SL. Res Dev Disabil; 2008 Sep 15; 29(3):247-55. PubMed ID: 17582739 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]